We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · July 30, 2020

Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma

JAMA Oncology

 

Additional Info

JAMA Oncology
Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial
JAMA Oncol 2020 Jul 23;[EPub Ahead of Print], R You, YP Liu, PY Huang, X Zou, R Sun, YX He, YS Wu, GP Shen, HD Zhang, CY Duan, SH Tan, JY Cao, JB Li, YL Xie, YN Zhang, ZQ Wang, Q Yang, M Lin, R Jiang, MX Zhang, YJ Hua, LQ Tang, AH Zhuang, QY Chen, L Guo, HY Mo, Y Chen, HQ Mai, L Ling, Q Liu, MLK Chua, MY Chen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading